Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-01
2009-12-01
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07625940
ABSTRACT:
A method for the treatment of systemic arterial hypertension, which is based on the oral administration to a patient suffering from systemic arterial hypertension either in an amount of chlorthalidone of 2.5-10 mg daily, alone or in novel combination use with another anti-hypertensive.agent.
REFERENCES:
patent: 3055904 (1962-09-01), Graf et al.
patent: 5948799 (1999-09-01), Cropp
Carter, B. L., Ernst, M. E., Cohen, J. D., “Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.” Hypertension (2004) 43:4-9. USA.
Materson, BJ, et al., Dose Response to Chlorthalidone in Patients With Mild Hypertension. Clinical Pharmacology and Therapeutics (1978) vol. 24(2):192-198.
Accu-Break Technologies, Inc.
Henley, III Raymond J
Whitlock Ted
LandOfFree
Method of treating hypertension with a very low dose of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hypertension with a very low dose of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hypertension with a very low dose of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4121169